Verona UL, Landrián IB, Padierne GN, Leiva GY, Román PY

Language: Spanish
References: 20
Page:
PDF size: 63.58 Kb.

ABSTRACT

Diabetes mellitus is a global health problem. It has been estimated that there are 120 million diabetics. One of the main complications of diabetes mellitus, diabetic retinopathy is among the leading causes of blindness in Cuba. A prospective longitudinal study was carried out to apply for the first time a therapeutic strategy in elderly with diabetic retinopathy and improve visual quality, in the retina consultation of Ophthalmology service of Provincial General Teaching Hospital Dr. "Antonio Luaces Iraola" Ciego Avila. The sample consisted of 180 patients. Variables of interest were used that poured into a clinical history previously drawn up. The age group most affected was 60-69 years and female was the predominant sex. Hypertension was the antecedent personal medical history most referred and eye cataracts as ocular history. The severity of retinopathy was increasing with age of the patients. It was applied to all eyes Tenon triamcinolone, macular grid and laser photocoagulation, achieving significant improvement in visual acuity of them. It assessed satisfaction degree by scale, patients reported being satisfied.

REFERENCES

1. Día mundial de la visión [Internet]. Venezuela; 2008 [actualizado 10 Sep 2008; citado 5 Dic 2010] [aprox. 12 pantallas]. Disponible en: http://www.abn.info.ve/gonews.php?articulo=21868agenciasdenoticias bolivariana.htm

2. Méndez T. Prevalencia de retinopatía diabética en un área de salud del municipio Marianao. Rev Cubana Oftalmol. 2006; 9(2):116-21.

3. Organización Mundial de la Salud. Vision 2020 the Right to sight. Ginebra: OMS; 2003.

4. Alemañy Martorell J, Villar Valdés R. Oftalmología. 5th ed. La Habana: Ciencias Médicas; 2005.

5. Vaughan D. Oftalmología General. México: El Manual Moderno; 2000.

6. Health Panamerican Organization. Declaración de las Américas sobre la diabetes. Panam Health Org Bull. 1996; 30(3):261-5.

7. Kanski JJ. Oftalmología clínica. 5 ed. Madrid: Harcourt; 2004.

8. Marín Bonilla MA. Retinopatía Diabética. Guatemala: Patronato del Diabético; 2007.

9. Chile. Ministerio de Salud Pública. Guía clínica de retinopatía diabética. Santiago: Ministerio de Salud Pública; 2006.

10. Eguía Martínez F. Manual de diagnóstico y tratamiento en Oftalmología. La Habana: MINSAP; 2009.

11. Ruíz Durán B. Retina Médica [Internet]. 2006 [citado 12 Sep 2010] [aprox. 20 pantallas]. Disponible en: http://www.sepeap.org/archivos/libros/OFTALMOLOGIA/Ar_1_8_44_APR_7.pdf

12. Pereira Delgado E. Nueva perspectiva en Oftalmologia: retinopatía diabética. Madrid: Esteve; 2005.

13. Sydorova M, Lee MS. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferate diabetic retinopathy or proliferate vitreoretinopathy. Ophthal Res. 2005; 37(4):188-90.

14. Rodríguez Villalobos E. Retinopatía diabética. Incidencia y progresión a 12 años. Cir Ciruj. 2005; 73:79-84.

15. López Gálvez MI. Escala internacional de severidad de retinopatia y del edema macular diabético. Arch Soc Esp Oftalm. 2004; 4: 117-121.

16. Brizzi Chizzotti MT. Retinal thickness assessed by optical coherence tomography (OCT) in pseudophakic macular edema. Arq Bras Oftalmol. 2006; 69(4): 539-544.

17. Duane TD, Tasman W, Jaeger EA, Anderson DR, Glaser JS, Grajewski AL, et al. Duane’s Ophthalmology on CD-ROM. Philadelphia: Lippincott Williams & Wilkins; 2006.

18. World Health Organization. Diabetes Mellitus. Report of a WHO Study Group. Thecnical report. Serie 727. Geneva: WHO; 2005.

19. Maciques Rodríguez E, García Ferrer L, Santana Pérez F, Licea Puig M. Evaluación de la retinopatía diabética proliferativa después del tratamiento con láser. Rev Cubana Endocrinol [Internet]. 2007 [citado 12 Dic 2010]; 18(3): [aprox. 5 pantallas]. Disponible en http://bvs.sld.cu/revistas/oft/vol9_2_96/oft08296.htm

20. Chew EY, Klein ML, Ferris FL. Association of elevated serum lipid levels with retinal exudates in Diabetic Retinopathy. Arch Ophthalmol. 2006; 114:1079-84.